93 related articles for article (PubMed ID: 9395243)
1. The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene.
Della Valle V; Duro D; Bernard O; Larsen CJ
Oncogene; 1997 Nov; 15(20):2475-81. PubMed ID: 9395243
[TBL] [Abstract][Full Text] [Related]
2. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
[TBL] [Abstract][Full Text] [Related]
3. The human p19ARF protein encoded by the beta transcript of the p16INK4a gene is frequently lost in small cell lung cancer.
Gazzeri S; Della Valle V; Chaussade L; Brambilla C; Larsen CJ; Brambilla E
Cancer Res; 1998 Sep; 58(17):3926-31. PubMed ID: 9731504
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitors of cyclins/CDK of the 9p21 chromosomal region and malignant hemopathies].
Quesnel B
Bull Cancer; 1998 Sep; 85(9):747-54. PubMed ID: 9817058
[TBL] [Abstract][Full Text] [Related]
5. [Alternative protein p19ARF: a genuine tumor suppressor gene].
Larsen CJ
Bull Cancer; 1998 Apr; 85(4):304-6. PubMed ID: 9752293
[TBL] [Abstract][Full Text] [Related]
6. [Tribulations of the p16/MTS1/CDKN2 tumor gene suppressor: a continuing saga].
Larsen CJ
Bull Cancer; 1997 Apr; 84(4):427-30. PubMed ID: 9238169
[TBL] [Abstract][Full Text] [Related]
7. Deletion of p16INK4A/CDKN2 and p15INK4B in human somatic cell hybrids and hybrid-derived tumors.
Kuerbitz SJ; Malandro J; Compitello N; Baylin SB; Graff JR
Cell Growth Differ; 1999 Jan; 10(1):27-33. PubMed ID: 9950215
[TBL] [Abstract][Full Text] [Related]
8. A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.
Duro D; Bernard O; Della Valle V; Berger R; Larsen CJ
Oncogene; 1995 Jul; 11(1):21-9. PubMed ID: 7624129
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract][Full Text] [Related]
10. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
11. Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization.
Munro J; Stott FJ; Vousden KH; Peters G; Parkinson EK
Cancer Res; 1999 Jun; 59(11):2516-21. PubMed ID: 10363964
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
[TBL] [Abstract][Full Text] [Related]
13. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas.
Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C
Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of the P16INK4/MTS1 gene by a chromosome translocation t(9;14)(p21-22;q11) in an acute lymphoblastic leukemia of B-cell type.
Duro D; Bernard O; Della Valle V; Leblanc T; Berger R; Larsen CJ
Cancer Res; 1996 Feb; 56(4):848-54. PubMed ID: 8631023
[TBL] [Abstract][Full Text] [Related]
15. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
Schmid M; Sen M; Rosenbach MD; Carrera CJ; Friedman H; Carson DA
Oncogene; 2000 Nov; 19(50):5747-54. PubMed ID: 11126361
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: implications for cellular senescence.
Zhu D; Xu G; Ghandhi S; Hubbard K
J Cell Physiol; 2002 Oct; 193(1):19-25. PubMed ID: 12209876
[TBL] [Abstract][Full Text] [Related]
17. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of CDKIs p15INK4b, p16INK4a and p21CIP1/WAF1 genes mediate growth arrest in human osteosarcoma cell lines.
Agiostratidou G; Derventzi A; Gonos ES
In Vivo; 2001; 15(5):443-6. PubMed ID: 11695244
[TBL] [Abstract][Full Text] [Related]
19. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
Elisei R; Shiohara M; Koeffler HP; Fagin JA
Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
[TBL] [Abstract][Full Text] [Related]
20. p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
Krimpenfort P; Ijpenberg A; Song JY; van der Valk M; Nawijn M; Zevenhoven J; Berns A
Nature; 2007 Aug; 448(7156):943-6. PubMed ID: 17713536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
